Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Queensland Health
Express Scripts

Generated: October 24, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,895,726

« Back to Dashboard

Summary for Patent: 4,895,726

Title: Novel dosage form of fenofibrate
Abstract:The present invention relates to a novel dosage form of fenofibrate containing fenofibrate and a solid surfactant which have been co-micronized. It also relates to the method for the preparation of this dosage form and its use for improving the bioavailabity in vivo.
Inventor(s): Curtet; Bernard (Marsanny la Cote, FR), Teillaud; Eric (Talant, FR), Reginault; Philippe (Fontaine les Dijon, FR)
Assignee: Fournier Innovation et Synergie (Paris, FR)
Application Number:07/299,073
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form; Formulation;

No matches for this query

Foreign Priority and PCT Information for Patent: 4,895,726

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France88 02359Feb 26, 1988

International Patent Family for Patent: 4,895,726

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office0330532► Subscribe
Germany68903846► Subscribe
Canada1322529► Subscribe
Australia2982889► Subscribe
Australia614577► Subscribe
Austria83374► Subscribe
Spain2054040► Subscribe
France2627696► Subscribe
Greece3006798► Subscribe
JapanH01254624► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Cantor Fitzgerald
Queensland Health
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus